Literature DB >> 5354945

Purification and properties of staphylococcal beta hemolysin. II. Purification of beta hemolysin.

R U Haque, J N Baldwin.   

Abstract

Staphylococcal beta hemolysin from the 681 strain of Staphylococcus aureus grown in a Heart Infusion dialysate semisolid medium under 10% carbon dioxide was obtained in an immunoelectrophoretically pure form by a combination of procedures of precipitation with 2 volumes of acetone followed by chromatography on diethylaminoethyl cellulose at pH 6.0. The acetone precipitation procedure did not show any deleterious effect on the hemolytic activity of the beta hemolysin unless the precipitate was left in contact with the acetone for at least 4 hr. The crude preparations contained two types of beta hemolysin. One of these represented the major portion of the total activity of beta hemolysin and behaved as a cation. The other represented a minor (1/5,000) portion of the total beta hemolysin activity and behaved as an anion. These active principles were designated as cationic and anionic beta hemolysins, respectively. An unexpected increase in the total beta hemolysin activity of the crude preparations was noted when these were concentrated by dialysis against polyethylene glycol (20 m). This effect was probably due to polyethylene glycol. A further unexpected increase in the titer of the acetone-precipitated preparations occurred when these were lyophilized. The reason for this incremental increase is not known. It may be due to fragmentation of the beta hemolysin.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5354945      PMCID: PMC250154          DOI: 10.1128/jb.100.2.751-759.1969

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  8 in total

1.  PURIFICATION AND PROPERTIES OF STAPHYLOCOCCAL BETA-HEMOLYSIN. I. PRODUCTION OF BETA-HEMOLYSIN.

Authors:  R U HAQUE; J N BALDWIN
Journal:  J Bacteriol       Date:  1964-11       Impact factor: 3.490

2.  [The application of continuous flow electrophoresis to the study of the enzymatic activity of protein fractions of the blood serum].

Authors:  A BLANCO
Journal:  Rev Fac Cienc Med Cordoba       Date:  1961 Jul-Sep

3.  Saphylococcal beta-hemolysin. I. Purification of beta-hemolysin.

Authors:  S K Maheswaran; K L Smith; R K Lindorfer
Journal:  J Bacteriol       Date:  1967-08       Impact factor: 3.490

4.  Properties of purified staphylococcal beta-hemolysin.

Authors:  J A Gow; J Robinson
Journal:  J Bacteriol       Date:  1969-03       Impact factor: 3.490

5.  The properties of phospholipase enzymes in staphylococcal toxins.

Authors:  H M Doery; B J Magnusson; J Gulasekharam; J E Pearson
Journal:  J Gen Microbiol       Date:  1965-08

6.  Identification of staphylococcal hemolysins by an electrophoretic localization technique.

Authors:  R U Haque
Journal:  J Bacteriol       Date:  1967-02       Impact factor: 3.490

7.  Staphylococcal beta-hemolysin. II. Phospholipase C activity of purified beta-hemolysin.

Authors:  S K Maheswaran; R K Lindorfer
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

8.  PURIFICATION OF STAPHYLOCOCCAL BETA-HEMOLYSIN AND ITS ACTION ON STAPHYLOCOCCAL AND STREPTOCOCCAL CELL WALLS.

Authors:  W R CHESBRO; F P HEYDRICK; R MARTINEAU; G N PERKINS
Journal:  J Bacteriol       Date:  1965-02       Impact factor: 3.490

  8 in total
  4 in total

Review 1.  The hemolysins of Staphylococcus aureus.

Authors:  G M Wiseman
Journal:  Bacteriol Rev       Date:  1975-12

2.  Purification and properties of staphylococcal delta hemolysin.

Authors:  A S Kreger; K S Kim; F Zaboretzky; A W Bernheimer
Journal:  Infect Immun       Date:  1971-03       Impact factor: 3.441

3.  CAMP-disk test for presumptive identification of group B streptococci.

Authors:  H W Wilkinson
Journal:  J Clin Microbiol       Date:  1977-07       Impact factor: 5.948

4.  Beta hemolysin: a persistent impurity in preparations of staphylococcal nuclease and enterotoxin.

Authors:  W Chesbro; V Kucic
Journal:  Appl Microbiol       Date:  1971-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.